Palamon Capital Partners said March 13 that it agreed to sell Ober Scharrer Group to Nordic Capital. Financial terms weren’t disclosed. Ober Scharrer, an ophthalmology group in Germany, provides more than 85,000 treatments per year through its clinics. The sale generated investment returns of 3.6x invested capital for Palamon.
